You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SLAMF7

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Charlottesville (SLAMF7 BATs)

Not yet recruiting
  • Multiple Myeloma
  • SLAMF7 BATs
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Multiple Myeloma Trial in Würzburg, Pamplona (SLAMF7 CAR-T)

Recruiting
  • Multiple Myeloma
  • SLAMF7 CAR-T
  • Würzburg, Germany
  • +1 more
Oct 5, 2021

Myeloma-Multiple, Myeloma, Plasma-Cell Trial run by the NCI (Cyclophosphamide, Fludarabine, Rimiducid)

Completed
Has Results
  • Myeloma-Multiple
  • Myeloma, Plasma-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 19, 2021

Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

Recruiting
  • Myelofibrosis Transformation in Essential Thrombocythemia
  • +2 more
  • Elotuzumab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Multiple Myeloma Trial in Little Rock (Elotuzumab, Lenalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jan 25, 2019

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Multiple Myeloma Trial (Elotuzumab)

No longer available
  • Multiple Myeloma
  • Elotuzumab
  • (no location specified)
Nov 17, 2021

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

PET/MR in Post Stroke Cardiac Inflammation Study

Recruiting
  • Stroke
  • Inflammation
  • cardiac PET/MRI
  • +2 more
  • London, Ontario, Canada
    Heart & Brain Lab, Western University
Mar 17, 2023

MR Evidence of Cardiac Inflammation Post-Stroke

Recruiting
  • Stroke, Ischemic
  • +2 more
  • Gadolinium-enhanced cardiac MRI
  • +2 more
  • London, Ontario, Canada
    Heart & Brain Lab, Western University
Feb 8, 2023

Immune Profiling in Multiple Myeloma

Recruiting
  • Multiple Myeloma
    • Torino, TO, Italy
      Aou Citta' Della Salute E Della Scienza Di Torino
    Apr 28, 2021

    IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

    Recruiting
    • IgG4 Related Disease
    • IgG4-RD
    • Atlanta, Georgia
    • +2 more
    Jul 13, 2022

    Newly Diagnosed, Previously Untreated Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Elotuzumab)

    Terminated
    Has Results
    • Newly Diagnosed, Previously Untreated Multiple Myeloma
    • San Francisco, California
    • +13 more
    Jun 29, 2021

    RRMM Trial in Lishui, Wenzhou (CAR-T therapy in Relapsed/Refractory multiple myeloma)

    Unknown status
    • RRMM
    • CAR-T therapy in Relapsed/Refractory multiple myeloma
    • Lishui, Zhejiang, China
    • +2 more
    Nov 16, 2020

    Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Multiple Myeloma
    • Refractory Multiple Myeloma
    • Biospecimen Collection
    • +9 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 1, 2023

    Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Alcalá de Henares, Madrid, Spain
    • +67 more
    Sep 23, 2022

    Multiple Myeloma Trial in Chengdu, Shenzhen (BCMA-CS1 cCAR T cells)

    Unknown status
    • Multiple Myeloma
    • BCMA-CS1 cCAR T cells
    • Chengdu, China
    • +1 more
    Nov 8, 2019

    Multiple Myeloma Trial in Paris (Elotuzumab)

    Withdrawn
    • Multiple Myeloma
    • Paris, France
      Hématologie et thérapie cellulaire, Hôpital Saint Antoine
    Jul 15, 2019

    Multiple Myeloma Trial in Little Rock (drug, procedure, biological)

    Withdrawn
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Jul 8, 2020

    Multiple Myeloma Trial (Elotuzumab, Bortezomib, Lenalidomide)

    Withdrawn
    • Multiple Myeloma
    • (no location specified)
    Apr 12, 2017